Under construction – not a live service
Sign in
Taking people in FranceNo phase

Studies patient outcomes after heart failure telemonitoring is stopped

Reviews how patients with heart failure fare after leaving a telemonitoring program.

Key facts

Who runs it
University Hospital, Clermont-Ferrand
Where
Clermont-Ferrand, FranceSee the site
Trial code
Registry title
Evaluation of Heart Failure Telemonitoring Eligibility Criteria
Status
Recruiting
People taking part
130 people, planned
Started
5 Dec 2025
Expected to end
Dec 2026
Type of study
Observational
Record updated
30 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with heart failure who were in the CARDIAUVERGNE telemonitoring program in 2023 or 2024 and were taken off it because they no longer met the program's criteria.

Age
Adults, 18 Years and older
Sex
All sexes can join.
Disease stage
Heart failure. Entry into the program needed heart failure within 12 months, or breathlessness of at least NYHA 2 together with NTproBNP of at least 1000pg/mL.
Earlier treatment
Must have been in the CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 and removed by medical decision because the eligibility criteria were no longer met.
Biomarker or test result
NTproBNP of at least 1000pg/mL (needed for entry into the program when the person has breathlessness at least NYHA 2).

Main reasons for not taking part

  • Left telemonitoring for another reason: own choice, death, medical reason, moving away, or not following the program
  • Cannot read and understand French

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • adults
  • able to read and understand french
  • included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg/mL) and excluded by medical decision as no longer presenting eligibillity criteria

Who cannot take part

  • Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance)

Where in France

  • CHU Clermont-FerrandClermont-Ferrand, FranceContact: Clément RIOCREUXTaking people

About the trial

What the trial wants to find out

CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of Eligibility Criteria for Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort
Plain-language title
Studies patient outcomes after heart failure telemonitoring is stoppedGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
30 July 2026